Navidea Biopharmaceuticals Inc (NAVB)

[cricket69]

Conference Call

Navidea Biopharmaceuticals Schedules Conference Call to Discuss Future Outlook and Outcomes of Court Trial
Download as PDF April 03, 2018
Conference call to take place Thursday April 5, 2018 at 8:30am E.T.

DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals (NYSE MKT: NAVB) (“Navidea” or “the Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it will host a conference call on April 5, 2018 at 8:30am E.T. to discuss its future outlook following the outcome of the court case in Texas with Capital Royalty Group (CRG).

Michael Goldberg, President and Chief Executive Officer, and Jed Latkin, Chief Financial and Operating Officer of Navidea, will host the call and provide an update on recent developments and the strategy going forward.

To participate in the call, please dial [phone] (toll-free) in the U.S. and Canada. The conference ID number is 6756561.

Event: Navidea Future Outlook and Trial Outcome Call
Date: Thursday, April 5, 2018
Time: 8:30am E.T.
U.S. & Canada Dial-in: [phone] (toll free)
Conference ID: 6756561

A live audio webcast of the conference call will also be available on the investor relations page of Navidea’s corporate website at www.navidea.com. In addition, the recorded conference call can be replayed and will be available for 90 days following the call on Navidea’s website.